STOCK TITAN

Quantum-Si Incorporated - QSI STOCK NEWS

Welcome to our dedicated news page for Quantum-Si Incorporated (Ticker: QSI), a resource for investors and traders seeking the latest updates and insights on Quantum-Si Incorporated.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Quantum-Si Incorporated's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Quantum-Si Incorporated's position in the market.

Rhea-AI Summary
Quantum-Si Incorporated (Nasdaq: QSI) will report its first-quarter 2024 financial results on May 9, 2024. The Company, known as The Protein Sequencing Company™, will host a conference call at 4:30 PM ET on the same day to discuss financial results and provide a business update.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.97%
Tags
conferences earnings
-
Rhea-AI Summary
Quantum-Si Incorporated (Nasdaq: QSI) appoints Paula Dowdy, a seasoned executive with 35+ years of experience, to its Board of Directors. Dowdy's expertise in life sciences and technology industries, including roles at Illumina and Cisco Systems, brings valuable insights to Quantum-Si's growth strategy and global operations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.79%
Tags
management
-
Rhea-AI Summary
Quantum-Si Incorporated (NASDAQ: QSI) will showcase its Next-Generation Protein Sequencing instrument, Platinum, and recent enhancements at the 20th Anniversary US HUPO Conference. Researchers will present data from Platinum, demonstrating deeper insights into proteins. Justyna Fert-Bober and Kenneth Skinner will lead a Breakfast Seminar on Next-Generation Protein Sequencing and Mass Spectrometry. Quantum-Si aims to bring single-molecule proteomics to labs worldwide.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
29.81%
Tags
none
Rhea-AI Summary
Quantum-Si Inc. (QSI) announces financial results for Q4 2023, with revenue of $400,000. The Company is finalizing commercial readiness for a full commercial launch by Q1 2024. They have launched a new sequencing kit and added a third international distribution partner. Full year 2024 financial guidance has been provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.78%
Tags
-
Rhea-AI Summary
Esteemed scientist Dr. Christopher Mason of Weill Cornell Medicine will discuss his Two Frontiers Project using Quantum-Si's protein sequencer, Platinum®, in an exclusive webinar hosted by GenomeWeb. The focus is on expanding multiomic research on extremophiles and understanding human survival in extreme environments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.36%
Tags
none
-
Rhea-AI Summary
Quantum-Si Incorporated (Nasdaq: QSI) will report financial results for Q4 and full year 2023 on February 29, 2024. The Company will host a conference call to discuss financial results and provide a business update on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.94%
Tags
conferences earnings
Rhea-AI Summary
Quantum-Si Incorporated (Nasdaq: QSI) has announced the launch of new platform enhancements for Platinum®, with the release of its new V2 Sequencing Kits. The enhancements include increased sequencing performance, the ability to identify unknown proteins, high reproducibility across runs, and a 3-fold reduction in cost per amino acid. These improvements aim to make protein sequencing more accessible and cost-efficient for researchers, catering to the evolving needs of a diverse customer base.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.97%
Tags
none
-
Rhea-AI Summary
Quantum-Si Incorporated (Nasdaq: QSI) has announced a new distribution agreement with TOMY Digital Biology Co., Ltd. to make its protein sequencing instrument, Platinum®, available in Japan. This partnership will enable Japanese researchers to access Quantum-Si's next-generation protein sequencer™ and associated consumables, marking a significant step forward in scientific innovation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.11%
Tags
none
-
Rhea-AI Summary
Quantum-Si Incorporated (Nasdaq: QSI) has entered into an agreement with a new international distributor, 3Genes Distribution a.s., to distribute its next-generation protein sequencing instrument, Platinum, across Eastern Europe. This strategic move follows a previous agreement with ELTA 90 to distribute Platinum in Southeast Europe, reflecting the company's mission to revolutionize proteomics and expand its global reach.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.99%
Tags
none
Rhea-AI Summary
Quantum-Si Incorporated (Nasdaq: QSI) has announced a distribution agreement with Elta 90 to distribute its Platinum™ instrument and consumables in Southeast Europe. This partnership aims to meet the growing demand for next-generation protein sequencing™ platform, which offers single-molecule amino acid resolution. The agreement is expected to accelerate scientific research and expand the field of proteomics, making the technology more accessible to scientists in every lab, everywhere.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.75%
Tags
none
Quantum-Si Incorporated

Nasdaq:QSI

QSI Rankings

QSI Stock Data

239.59M
102.13M
19.1%
39.98%
5.32%
Other Measuring and Controlling Device Manufacturing
Manufacturing
Link
United States
Branford

About QSI

at quantum-si we have a created a very unique environment where bright, highly committed individuals are given the freedom, ownership, and resources to solve tough problems and be the first to do new science. we are fully-funded by successful founders so employees can focus on creating, building, learning, and getting to market products that will change the world. if you are looking for a new challenge, check out our job postings at https://www.4catalyzer.com empower discovery. empower health. empower you.